Actively Recruiting Studies

Obstetrics

HOPE (Heart Outcomes in Pregnancy Expectations) (Dr. Cecila Avila)


Where:
Recruiting outpatient pregnant women with heart conditions

Inclusion criteria:
1. 18 years or older
2. Any pregnant person at any point in gestation (with singleton or multiple gestation) prior to delivery.
3. English and/or Spanish speaking
4. Attends at least one cardio obstetrics clinic visit
5. Must have one or more of the conditions within the following 6 categories
  a.  Congenital or structural heart disease
  b.  Aortopathies
  c.  Arrhythmia
  d.  Cardiomyopathies and heart failure
  e.  Coronary disease
  f.  Other

Exclusion criteria:
1.  Previously enrolled in HOPE (current study).
2.  Unable to participate in follow-up
  a.  Incarcerated or current prisoner
  b.  Current diagnosis of dementia
  c.  Subjects without a way to contact for follow-up
3.   Refused participation in the study
4.   Unable to consent for self
5.   Traumatic aortic disease
6.   Perpartum cardiomyopathy diagnosed in the current pregnancy (new diagnosis)
Contact: alessa.ramosvargas@stonybrookmedicine.edu

IMPAACT 2041 (Dr. Sharon Nachman)


Where:
Recruiting pregnant patient with hepatitis C virus (HCV) to describe pharmacokinetics (PK) and safety of glecaprevir/pibrentasvir (GLE/PIB).

Inclusion criteria: 
Age: 16-45 years of age (inclusive)
GA: 14-32 weeks gestation, SINGLETON (no known anomalies, no growth restriction)
HCV status: At screening, detectable HCV RNA test result based on testing of a specimen collected within 30 days prior to enrollment.

Other labs within 30 days prior to enrollment:
•    Hepatitis B surface antigen negative
•    AST/ALT (<10.0 x ULN)
•    Hemoglobin (≥8.5 g/dL)
•    Creatinine (≤1.8 x ULN)
•    INR (<1.5 x ULN)
•    Platelet count (≥100,000 cells/mm3)
•    Total bilirubin (<1.6 x ULN)
•    HIV status
 
Exclusion criteria:

  1. Previous treatment for hepatitis C with a DAA regimen
  2. History of spontaneous preterm delivery at less than 34 weeks
  3. Shortened cervix less than 20 mm if noted on ultrasound
  4. Clinical diagnosis of acute hepatitis not otherwise attributable to hepatitis C with AST or ALT ≥2.5 x ULN, evidence of decompensated cirrhosis including history of or present variceal hemorrhage, ascites, spontaneous bacterial peritonitis, hepatic encephalopathy, hepatocellular carcinoma, hepatorenal syndrome, or hepatopulmonary syndrome
  5. Any medical condition that the site investigator that participation in the study would be unsafe
  6. Receipt of any prohibited medication within 14 days prior to entry:
    •    ARVs and pharmacoenhancers: (Atazanavir, Cobicistat, Darunavir, Efavirenz, Etravirine, Lopinavir, Ritonavir)
    •    HMG-CoA reductase inhibitors: (Atorvastatin, Lovastatin, Simvastatin)
    •    Other
    •    Carbamazepine
    •    Medications containing more than 20 mcg ethinyl estradiol (e.g., combined oral contraceptives)
    •    Proton pump inhibitors
    •    Rifampin, rifapentine, rifabutin
    •    Nirmatrelvir/ritonavir
    •    St. John’s wort (hypericum perforatum)
     
    Contact: David.Garry@stonybrookmedicine.edu & sharon.nachman@stonybrookmedicine.edu

Effect of Metformin on Vitamin B12 Levels in Pregnancy (Dr. Jennifer Choi)
 

Where:
Recruiting pregnant patient who failed GTT.

Inclusion criteria:

  • Women>18 years of age and pregnant
  • Diabetic (either gestational or pregestational)
  • Not already on metformin

Exclusion criteria:

  • Known B12 deficiency
  • Strict vegan diet
  • Known pernicious anemia (intrinsic factor deficiency)
  • Known malabsorptive diseases
  • Chronic pancreatitis
  • Imerslund-Graesbeck syndrome
  • History of gastric bypass 

Contact: samantha.gobioff@stonybrookmedicine.edu

RCT on Using Single (oxytocin) vs Double (oxytocin + misoprostol) Uterotonic Agents to Prevent Postpartum Hemorrhage (Dr. James Bernasko)

Where:
Recruiting patients prior to delivery on L&D.

Inclusion criteria:
All women 18 years and older admitted for delivery at Stony Brook University Hospital who agree to participate in the study.

Exclusion criteria:

  • Women under 18 years old
  • Women with known coagulation disorders
  • Women with planned cesarean hysterectomy - Women with known placental accreta spectrum disorders
  • Women with known allergy to prostaglandins
  • Women with known fetal demise

Contact: obgyn.sbresearch@stonybrookmedicine.edu

Perceived Agency in Decision Making for Cesarean Section (Dr. Joseph Chappelle) 

Where:
Recruiting post cesarean patients in the postpartum unit.

Inclusion criteria:

  • Individuals who underwent a Cesarean section at Stony Brook University Hospital and complete the first survey while inpatient after their delivery
  • Age>18 years
  • Speaks and reads English or Spanish as primary language

Exclusion criteria:

  • Delivery of nonviable infant, neonatal death
  • Current incarceration

Contact: angelina.mozier@stonybrookmedicine.edu

Circulating mRNAs from placental exosomes in pregnant women with substance use exposure (Dr. David Garry)

Where:
Recruiting patients in the third trimester who are on medications for OUD and a healthy control group.

Inclusion criteria:

  • Have a viable pregnancy, 28 weeks gestation or greater
  • 18 years of age or older
  • Diagnosed with opioid use disorder (OUD), which is defined as misuse of prescribed opioid medications, use of diverted opioid medications, or use of illicitly obtained opioids (i.e. heroin).
  • Medication for Opioid Use Disorder (MOUD) with buprenorphine or buprenorphine/naloxone
  • Be planning to be delivered at Stony Brook University Hospital.
     

Exclusion criteria:

  • Multiple gestations
  • Carrying a fetus with known aneuploidy or anomaly
  • Non-English speaking
  • Pregnancy complicated by any of the following: Class 3 obesity, any form of hypertension, pre-gestational diabetes, rheumatologic disorders, fetal growth restriction (below 10%-tile), experiences delivery below 37 weeks, or other drug/substance use

Contact: Rachel.lee@stonybrookmrdicine.edu

Gynecology

Medicaid Sterilization Perceptions (Dr. Joseph Chappelle) 

Where:
Recruiting patients during the 6 week postpartum visit

Inclusion criteria:

Providers 

  • OB/GYN physicians in Long Island and New York City

Patients

  • 18 years of age or older
  • Stony Brook patients presenting for post-partum visit

Contact: Alexa.PezzulichCourtepatte@stonybrookmedicine.edu

Gynecologic Oncology

Ovarian Cancer Organoid Study (Dr. William Burke & Dr. Medhi Damaghi) 

Where:
Recruiting patients during the 6 week postpartum visit

Inclusion criteria:

  • Age > 18 years

Exclusion criteria:

  • Age < 18 years
    Unable to consent

Contact: mehdi.damaghi@stonybrookmedicine.edu   elayna.kirsch@stonybrookmedicine.edu
 

Salpingectomy vs. Salpingo-oophorectomy to reduce ovarian cancer risk in BRCA1 carriers  (Dr. William Burke)

Where:
Recruiting patients with BRCA1 that did not have ovarian cancer risk reduction surgery.

Contact: Catherine.Izzo@stonybrookmedicine.edu

Randomized phase 3 trial on use of immunochemotherapy (Olvi-Vec) for ovarian 
cancer treatment (Dr. William Burke)

Where:
Recruiting patients with platinum-resistant/ refractory ovarian cancer.

Contact: Catherine.Izzo@stonybrookmedicine.edu


Collaborations

PCOS and gut microbiome (Dr. Olga Aroniadis (Medicine)


Where:
Recruiting OCP naive patients during their first to the PCOS Center

Contact: Joseph.Lacomb@stonybrookmedicine.edu 

Cord Blood Survey (Dr. Thomas Diacovo (Pediatrics)


Where:
Recruiting second and third trimester patients in outpatient clinics

Contact: barsha.chakraborty@stonybrookmedicine.edu


Brain Imaging of Mothers (BIOM) (Dr. James Swain) 

Where: 
Recruiting pregnant or up to five year postpartum including those with OUD, mental health illness, or healthy controls. 

Inclusion criteria:

  • Currently pregnant or have given birth within the past 5 years
  • Able to understand and comprehend English to provide informed written consent and understand all study requirements
  • History of- or diagnosis of- opioid use disorder, history of- or diagnosis of- a mental health disorder (e.g., anxiety, depression, PTSD), or healthy control without diagnosis of a mental health disorder

Exclusion criteria:

  • Minors (under 18 years old)
  • Those unable to give their consent for participation (i.e., those with legal guardians)
  • Individuals who require immediate clinical care for suicidal or homicidal risk and/or meet the criteria for a psychotic disorder
  • Inability to undergo an fMRI brain scan (e.g., claustrophobia, piercings, metal in body)

Contact: elle.eggers@stonybrookmedicine.edu

ROOTS Study (Dr. Kristin Bernard (Psychology)) 

Where: 
Black and Latina patients in the third trimester

Contact: lauren.morrison@stonybrook.edu